{"id":36865,"date":"2015-09-18T08:44:43","date_gmt":"2015-09-18T12:44:43","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=36865"},"modified":"2015-09-18T08:44:43","modified_gmt":"2015-09-18T12:44:43","slug":"pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865","title":{"rendered":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) To Establish IND Team (NPHC,ULUR)"},"content":{"rendered":"

Providing updates on objectives, Pharmacyte Biotech Inc (OTCMKTS:PMCB)<\/strong> reported<\/a> that it will form an IND team to design the IND and assess it before being officially filed with the regulatory authorities. He company\u2019s IND Team will include a Project Manager, a Medical Officer, a Statistician, a Chemistry, Controls and Manufacturing Expert, a Pharmacologist, a Pharmakineticist, a Toxicologist, an Interventional Radiologist, a Radiologist, and a Regulatory Affairs person.<\/p>\n

Pharmacyte also reported that with pivotal input from its team of oncologists, the plan of its clinical study will be finalized with an objective of formulating the highest probability of developing encouraging data during the study that could result in marketing approval of pancreatic cancer treatment.<\/p>\n

In last trading session, the stock price of Pharmacyte declined more than 3% to close the trading session at $0.0878. The decline came at a share volume of 1.85 million compared to average monthly share volume of 1.41 million. After the recent drop, the market cap of company stands at 65.27 million.<\/p>\n

Nutra Pharma Corp. (OTCMKTS:NPHC)<\/strong> received<\/a> Orphan Drug designation for RPI-78M targeting Multiple Sclerosis in children. The company operates as a biotechnology firm marketing Nyloxin\u00ae and Pet Pain-Away, and formulating drugs for the treatment of Adrenomyeloneuropathy, Multiple Sclerosis and Human Immunodeficiency Virus.<\/p>\n

The Company specializes in the licensing, acquisition and commercialization of pharmaceutical products for the management of neurological disorders, infectious diseases, cancer and autoimmune.<\/p>\n

Uluru Inc (OTCMKTS:ULUR)<\/strong> reported<\/a> 2Q2015 results wherein it revealed that Research and development expenses surged to $219,000 in 2Q from $184,000 in the same quarter, a year earlier. The R&D expenses included $19,000 in share-based compensation compared to $5,000 in share-based compensation in second quarter of 2014.<\/p>\n

This increase in research and development expenses can be attributed to $16,000 jump in scientific compensation associated with share-based compensation and increased direct research costs related to Altrazeal\u00ae.<\/p>\n","protected":false},"excerpt":{"rendered":"

Providing updates on objectives, Pharmacyte Biotech Inc (OTCMKTS:PMCB) reported that it will form an IND team to design the IND and assess it before being […]<\/p>\n","protected":false},"author":32,"featured_media":25333,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[11651,11650,11652,11643,11679,11642,11641,11678,11677],"stock_ticker":[],"class_list":["post-36865","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nutra-pharma-corp","tag-nutra-pharma-corp-otcmktsnphc","tag-otcmktsnphc","tag-otcmktspmcb","tag-otcmktsulur","tag-pharmacyte-biotech-inc","tag-pharmacyte-biotech-inc-otcmktspmcb","tag-uluru-inc","tag-uluru-inc-otcmktsulur","entry"],"acf":[],"yoast_head":"\nPharmacyte Biotech Inc (OTCMKTS:PMCB) To Establish IND Team (NPHC,ULUR) - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) To Establish IND Team (NPHC,ULUR) - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Providing updates on objectives, Pharmacyte Biotech Inc (OTCMKTS:PMCB) reported that it will form an IND team to design the IND and assess it before being […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-09-18T12:44:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Synthetic-Biologics-Inc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"259\" \/>\n\t<meta property=\"og:image:height\" content=\"194\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) To Establish IND Team (NPHC,ULUR)\",\"datePublished\":\"2015-09-18T12:44:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865\"},\"wordCount\":311,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Synthetic-Biologics-Inc.jpg\",\"keywords\":[\"Nutra Pharma Corp.\",\"Nutra Pharma Corp. (OTCMKTS:NPHC)\",\"OTCMKTS:NPHC\",\"OTCMKTS:PMCB\",\"OTCMKTS:ULUR\",\"Pharmacyte Biotech Inc\",\"Pharmacyte Biotech Inc (OTCMKTS:PMCB)\",\"Uluru Inc\",\"Uluru Inc (OTCMKTS:ULUR)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865\",\"name\":\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) To Establish IND Team (NPHC,ULUR) - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Synthetic-Biologics-Inc.jpg\",\"datePublished\":\"2015-09-18T12:44:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Synthetic-Biologics-Inc.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Synthetic-Biologics-Inc.jpg\",\"width\":259,\"height\":194},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmacyte Biotech Inc (OTCMKTS:PMCB) To Establish IND Team (NPHC,ULUR)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) To Establish IND Team (NPHC,ULUR) - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865","og_locale":"en_US","og_type":"article","og_title":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) To Establish IND Team (NPHC,ULUR) - Wall Street PR","og_description":"Providing updates on objectives, Pharmacyte Biotech Inc (OTCMKTS:PMCB) reported that it will form an IND team to design the IND and assess it before being […]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2015-09-18T12:44:43+00:00","og_image":[{"width":259,"height":194,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Synthetic-Biologics-Inc.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) To Establish IND Team (NPHC,ULUR)","datePublished":"2015-09-18T12:44:43+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865"},"wordCount":311,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Synthetic-Biologics-Inc.jpg","keywords":["Nutra Pharma Corp.","Nutra Pharma Corp. (OTCMKTS:NPHC)","OTCMKTS:NPHC","OTCMKTS:PMCB","OTCMKTS:ULUR","Pharmacyte Biotech Inc","Pharmacyte Biotech Inc (OTCMKTS:PMCB)","Uluru Inc","Uluru Inc (OTCMKTS:ULUR)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865","url":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865","name":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) To Establish IND Team (NPHC,ULUR) - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Synthetic-Biologics-Inc.jpg","datePublished":"2015-09-18T12:44:43+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Synthetic-Biologics-Inc.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/Synthetic-Biologics-Inc.jpg","width":259,"height":194},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pharmacyte-biotech-inc-otcmktspmcb-to-establish-ind-team-nphculur-36865#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Pharmacyte Biotech Inc (OTCMKTS:PMCB) To Establish IND Team (NPHC,ULUR)"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36865","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=36865"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36865\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/25333"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=36865"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=36865"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=36865"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=36865"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}